INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 438s ago
HOUSE PTR6h ago
SEC 13F6h ago
ROBINHOOD CHAIN6h ago
SEC FORM 4/Open-market purchaseVerified data

Wambeke David J. bought NMTC

Chief Business Officer · NEUROONE MEDICAL TECHNOLOGIES Corp · Common Stock

Side
BUY
Value
$67K
Shares
33.3K
Price
$2.01
Executed
Aug 27, 2026
Disclosed
Sep 8, 2026
Disclosure timeline12 days from execution to publication · legal deadline 2 business days
Aug 27 executedSep 8, 2026 disclosed

NMTC · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
46/ 100 · ELEVATED
Methodology →
  • Transaction type+20 / 20

    Open-market purchase

  • Relative size+8 / 25

    $67K reported value · 20.0% of prior position

  • Filing timing+10 / 15

    Disclosed 8 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · NMTC

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    15
    WJ
    Wambeke David J.Chief Business Officer
    NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
    Grant or award
    		A—
    35.0K sh
    		Aug 28, 2026Sep 8, 2026
    traded Aug 28, 2026
    		+11dSEC FORM 4

    Evidence

    9
    RA
    Rosa David ADirector, CEO & President
    NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
    Grant or award
    		A—
    68.0K sh
    		Aug 28, 2026Aug 28, 2026
    traded Aug 28, 2026
    		+0dSEC FORM 4

    Evidence

    9
    JJ
    Johns Emily J.Chief Administrative Officer
    NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
    Grant or award
    		A—
    12.5K sh
    		Aug 28, 2026Aug 28, 2026
    traded Aug 28, 2026
    		+0dSEC FORM 4

    Evidence

    9
    VC
    Volker ChristopherChief Financial Officer
    NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
    Grant or award
    		A—
    35.0K sh
    		Aug 28, 2026Aug 28, 2026
    traded Aug 28, 2026
    		+0dSEC FORM 4

    Evidence

    9
    MS
    Mertens SteveChief Technology Officer
    NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
    Grant or award
    		A—
    15.0K sh
    		Aug 28, 2026Aug 28, 2026
    traded Aug 28, 2026
    		+0dSEC FORM 4

    Evidence

    9
    CM
    Christianson MarkMarket Development Director
    NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
    Grant or award
    		A—
    12.5K sh
    		Aug 28, 2026Aug 28, 2026
    traded Aug 28, 2026
    		+0dSEC FORM 4

    Evidence

    21
    MR
    Mills Jason RichardDirector
    NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
    Grant or award
    		A—
    41.9K sh
    		Apr 3, 2026Apr 7, 2026
    traded Apr 3, 2026
    		+4dSEC FORM 4

    Evidence

    9
    MR
    Mills Jason RichardDirector
    NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
    Grant or award
    		A—
    26.0K sh
    		Apr 3, 2026Apr 7, 2026
    traded Apr 3, 2026
    		+4dSEC FORM 4

    Evidence

    19
    MR
    Mills Jason RichardDirector
    NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
    Grant or award
    		A—
    7,758 sh
    		Dec 18, 2025Jan 2, 2026
    traded Dec 18, 2025
    		+15dSEC FORM 4

    Evidence

    19
    MR
    Mills Jason RichardDirector
    NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
    Grant or award
    		A—
    4,806 sh
    		Dec 18, 2025Jan 2, 2026
    traded Dec 18, 2025
    		+15dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001971798-26-000005
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Aug 27, 2026
    Published
    Sep 8, 2026
    Ingested by INSIDER
    Nov 5, 02:18 UTC
    Last re-read
    Nov 5, 02:18 UTC

    Extracted facts

    Filer
    Wambeke David J.
    Role
    Chief Business Officer
    Transaction
    Open-market purchaseAs filed: “P”
    Asset
    NEUROONE MEDICAL TECHNOLOGIES Corp
    Ticker
    NMTC
    Shares
    33.3K
    Price per share
    $2.01
    Value
    $66,999
    Execution date (reported)
    Aug 27, 2026
    Owned after transaction
    200.0K shares
    Days from execution to publication
    12

    Calculation

    Value = shares × reported price per share

    • Shares: 33.3K
    • Price: $2.01

    = $66,999

    What this establishes

    Wambeke David J. filed this Form 4 reporting a open-market purchase of NMTC on Aug 27, 2026. It became public on Sep 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Business Officer
    Wambeke David J.cik:0001971798
    Issuer
    NEUROONE MEDICAL TECHNOLOGIES Corpcik:0001500198

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.